Wordt geladen...
HCV eradication induced by direct-acting antiviral agents reduces the risk of hepatocellular carcinoma
BACKGROUND AND AIMS: It is unclear whether direct-acting antiviral (DAA) treatment-induced sustained virologic response (SVR) reduces the risk of hepatocellular carcinoma (HCC) in patients with hepatitis C virus (HCV) infection. We aimed to determine the impact of DAA-induced SVR on HCC risk. METHOD...
Bewaard in:
| Gepubliceerd in: | J Hepatol |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2017
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5837901/ https://ncbi.nlm.nih.gov/pubmed/28887168 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jhep.2017.08.030 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|